{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:26Z","timestamp":1790713226032,"version":"4.1.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejmech.2019.03.020","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T06:48:06Z","timestamp":1552286886000},"page":"173-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Current advances of triazole alcohols derived from fluconazole: Design, in\u00a0vitro and in silico studies"],"prefix":"10.1016","volume":"170","author":[{"given":"Saeed","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Ghobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Saednia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Mahdieh","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.03.020_bib1","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging new targets for the treatment of resistant fungal infections","volume":"61","author":"Liu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2016.11.019","volume":"133","author":"Campoy","year":"2017","journal-title":"Antifungals. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib3","first-page":"687","article-title":"Antifungal resistance and new strategies to control fungal infections","volume":"26","author":"Vandeputte","year":"2012","journal-title":"Internet J. Microbiol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib6","first-page":"1","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"57","author":"Bongomin","year":"2017","journal-title":"J.\u00a0Fungi (Basel)"},{"key":"10.1016\/j.ejmech.2019.03.020_bib7","doi-asserted-by":"crossref","first-page":"5679","DOI":"10.1021\/acs.jmedchem.8b00641","article-title":"Sterol 14\u03b1-demethylase structure-based design of VNI derivatives to target fungal infections: synthesis, biological evaluation, and crystallographic analysis","volume":"61","author":"Friggeri","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib8","first-page":"1","article-title":"New horizons in antifungal therapy","volume":"2","author":"Pianalto","year":"2016","journal-title":"J.\u00a0Fungi."},{"key":"10.1016\/j.ejmech.2019.03.020_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14728214.2016.1155554","article-title":"Is there an emerging need for new antifungals?","volume":"21","author":"Perfect","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2019.03.020_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QCO.0b013e32835ebcb7","article-title":"New antifungal antibiotics","volume":"26","author":"Paiva","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tim.2010.02.004","article-title":"Therapy for fungal diseases: opportunities and priorities","volume":"18","author":"Denning","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jam.13301","article-title":"Fungal cell membrane-promising drug target for antifungal therapy","volume":"121","author":"Sant","year":"2016","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejmech.2013.06.008","article-title":"Synthesis, in\u00a0vitro antifungal activity and in silico study of 3-(1,2,4-triazol-1-yl)flavanones","volume":"66","author":"Emami","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib15","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1016\/j.bmc.2012.04.045","article-title":"The biology and chemistry of antifungal agents","volume":"20","author":"Kathiravan","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib16","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.3390\/molecules15064129","volume":"15","author":"Heeres","year":"2010","journal-title":"Conazoles, Mol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-2008-1063858","article-title":"Update on azole antifungals","volume":"29","author":"Zonios","year":"2008","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2019.03.020_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","article-title":"Triazole antifungals: a review","volume":"51","author":"Peyton","year":"2015","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ejmech.2019.03.020_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543776.2014.876993","article-title":"Novel antifungal agents","volume":"24","author":"Castelli","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.03.020_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2019.03.020_bib21","first-page":"130","article-title":"Antifungal agents: mode of action in yeast cells","volume":"19","author":"Carrillo-Munoz","year":"2006","journal-title":"Rev. Espa\u00f1ola Quimioter."},{"key":"10.1016\/j.ejmech.2019.03.020_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2017.06.018","article-title":"Molecular bases of antifungal resistance in filamentous fungi","volume":"50","author":"Sharma","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.03.020_bib23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.02067-12","article-title":"Azole affinity of sterol 14\u03b1-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens","volume":"57","author":"Warrilow","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.03.020_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2010.06.006","article-title":"Structural basis for conservation in the CYP51 family","volume":"1","author":"Lepesheva","year":"2011","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2019.03.020_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/fcp.12230","article-title":"Targeting CYP51 for drug design by the contributions of molecular modelling","volume":"31","author":"Rabelo","year":"2017","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib27","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.1324245111","article-title":"Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer","volume":"111","author":"Monk","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.03.020_bib28","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1128\/AAC.00925-15","article-title":"Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14\u03b1-demethylase","volume":"59","author":"Sagatova","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.03.020_bib29","doi-asserted-by":"crossref","first-page":"23916","DOI":"10.1074\/jbc.M115.677310","article-title":"Structure-functional characterization of cytochrome P450 sterol 14\u03b1-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs","volume":"290","author":"Hargrove","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2017.02.035","article-title":"New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies","volume":"130","author":"Dogan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2018.06.022","article-title":"Novel carbazole-triazole conjugates as DNA-targeting membrane active potentiators against clinical isolated fungi","volume":"155","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejmech.2014.05.079","article-title":"Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains","volume":"82","author":"Jiang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib33","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/jm051211n","article-title":"Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking","volume":"49","author":"Sheng","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molstruc.2017.05.065","article-title":"3D-QSAR modeling and molecular docking studies on a series of 2,5-disubstituted 1,3,4-oxadiazoles","volume":"1145","author":"Ghaleb","year":"2017","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2019.03.020_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib36","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1016\/j.bmcl.2009.07.144","article-title":"Discovery of highly potent novel antifungal azoles by structure-based rational design","volume":"19","author":"Wang","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tox.2006.08.007","article-title":"Comparison of lanosterol-14-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles","volume":"228","author":"Trosken","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2019.03.020_bib38","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3987\/COM-01-9301","article-title":"Stereoselective syntheses of (E)- and (Z)-2,3-dihydro-3-(1,2,4-triazolyl)-4H-1-benzopyran-4-one oxime ethers","volume":"55","author":"Emami","year":"2001","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2019.03.020_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1021\/jo00264a048","article-title":"Synthesis of 1-alkyl-1,2,4-triazoles: a new one-pot regiospecific procedure","volume":"54","author":"Astleford","year":"1989","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bioorg.2018.03.001","article-title":"Design, synthesis, in\u00a0vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents","volume":"78","author":"Dehestani","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib41","unstructured":"B. Jinyuan, H. Yan Ge, D. Wei, J. Yuwei, Z. Xiaoqing, Synthesis Method of Efinaconazole and Intermediate Thereof. Patent; CN104292214(A) (2017)."},{"key":"10.1016\/j.ejmech.2019.03.020_bib42","unstructured":"X. Xuenong, Preparation Method of Efinaconazole, Patent; CN104327047 (A) (2015)."},{"key":"10.1016\/j.ejmech.2019.03.020_bib43","unstructured":"F. Peng, Chengdu qiesite science and Technology Co., Ltd; Patent; CN105541739; (2016); (A) Chinese."},{"key":"10.1016\/j.ejmech.2019.03.020_bib44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3797\/scipharm.1501-13","article-title":"Synthesis of isomeric and potent impurities of the triazole-based antifungal drug voriconazole","volume":"83","author":"Sundaram","year":"2015","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2019.03.020_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejmech.2017.03.075","article-title":"Novel alkylated azoles as potent antifungals","volume":"133","author":"Shrestha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2019.03.020_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1358\/dof.1985.010.12.51933","volume":"10","author":"Fromtling","year":"1985","journal-title":"Fluconazole. Drugs Fut."},{"key":"10.1016\/j.ejmech.2019.03.020_bib47","first-page":"234","article-title":"Studies on the synthesis of 3-substituted benzo[b]furans by intramolecular SNAr on 2(2'-fluoroaryl)-2-(1-azolylmethyl)oxiranes","author":"Santamaria","year":"2007","journal-title":"ARKIVOC"},{"key":"10.1016\/j.ejmech.2019.03.020_bib48","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.tetlet.2006.03.199","article-title":"Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1, 2, 4-triazol-1-yl) propan-2-ols as antifungal agents","volume":"47","author":"Lebouvier","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.03.020_bib49","first-page":"344","article-title":"Optimization of the synthesis of the key intermediate of fluconazole by the orthogonal experimental design","volume":"12","author":"Sheng","year":"2002","journal-title":"Chin. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib50","first-page":"1","article-title":"Novel synthesis and biological evaluation of 1,2,4-triazole","volume":"3","author":"Hole","year":"2014","journal-title":"Int. J. Innovations Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.03.020_bib51","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bmc.2017.12.018","article-title":"Novel fluconazole derivatives with promising antifungal activity","volume":"26","author":"Thamban Chandrika","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cmdc.200900468","article-title":"Improved model of lanosterol 14\u03b1-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization","volume":"5","author":"Sheng","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2012.04.013","article-title":"Design, synthesis and structure\u2013activity relationships of new triazole derivatives containing N-substituted phenoxypropylamino side chains","volume":"53","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib54","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ardp.200900103","article-title":"Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives","volume":"342","author":"Wang","year":"2009","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2019.03.020_bib55","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/cjoc.201300430","article-title":"Asymmetric synthesis, antifungal activity and molecular modeling of iodiconazole isomers","volume":"31","author":"Zhang","year":"2013","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib56","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.bmcl.2008.02.027","article-title":"Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents","volume":"18","author":"Giraud","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/cmdc.201000530","article-title":"Design, synthesis, and in\u00a0vitro antifungal activity of 1-[(4-substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols","volume":"6","author":"Guillon","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib58","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/cmdc.201100262","article-title":"Design, synthesis, and biological evaluation of 1-[(biarylmethyl) methylamino]-2-(2, 4-difluorophenyl)-3-(1H-1, 2, 4-triazol-1-yl) propan-2-ols as potent antifungal agents: new insights into structure\u2013activity relationships","volume":"6","author":"Guillon","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib59","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.bmcl.2009.01.048","article-title":"Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols","volume":"19","author":"Chai","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib60","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ejmech.2008.11.007","article-title":"Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase","volume":"44","author":"Chai","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib61","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1747-0285.2010.01038.x","article-title":"Synthesis, molecular docking, and biological evaluation of novel triazole derivatives as antifungal agents","volume":"76","author":"Guan","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.03.020_bib62","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/cbdv.200790125","article-title":"Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14\u03b1-demethylase (CYP51)","volume":"4","author":"Zhao","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2019.03.020_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cclet.2013.01.015","article-title":"Synthesis and biological evaluation of novel triazole derivatives as antifungal agents","volume":"24","author":"Tang","year":"2013","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.03.020_bib64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1747-0285.2011.01138.x","article-title":"Structure-based design, synthesis, and antifungal activity of new triazole derivatives","volume":"78","author":"Sheng","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.03.020_bib65","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.bmcl.2009.08.089","article-title":"Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols","volume":"19","author":"Guillon","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bmcl.2008.11.101","article-title":"Synthesis and structure\u2013activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents","volume":"19","author":"Giraud","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s12272-013-0063-0","article-title":"Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment","volume":"36","author":"Yu","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2019.03.020_bib68","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1039\/c3ra41310a","article-title":"Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives containing the 1,2,3-triazole group","volume":"3","author":"Yu","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.03.020_bib69","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.ejmech.2010.07.002","article-title":"Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14\u03b1-demethylase","volume":"45","author":"Yu","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmech.2013.04.025","article-title":"Discovery of highly potent triazole antifungal derivatives by heterocycle-benzene bioisosteric replacement","volume":"64","author":"Jiang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib71","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.3390\/molecules190811333","article-title":"Synthesis and antifungal activity of novel triazole compounds containing piperazine moiety","volume":"19","author":"Wang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.03.020_bib72","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ejmech.2007.01.006","article-title":"Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14\u03b1-demethylase (CYP51)","volume":"42","author":"Sun","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib73","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.ejmech.2011.02.042","article-title":"Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives","volume":"46","author":"Xu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib74","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bmcl.2010.12.006","article-title":"New azoles with antifungal activity: design, synthesis, and molecular docking","volume":"21","author":"Chai","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib75","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.ejmech.2011.04.022","article-title":"Design, synthesis and molecular docking studies of novel triazole as antifungal agent","volume":"46","author":"Chai","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib76","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ejmech.2006.11.003","article-title":"Synthesis and evaluation of novel 1-(1H-1, 2, 4-triazol-1-yl)-2-(2, 4-difluorophenyl)-3-[(4-substitutedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents","volume":"42","author":"Sun","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib77","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1016\/j.ejmech.2009.05.018","article-title":"New azoles with potent antifungal activity: design, synthesis and molecular docking","volume":"44","author":"Che","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib78","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.ejmech.2011.03.019","article-title":"Design and synthesis of novel triazole antifungal derivatives by structure-based bioisosterism","volume":"46","author":"Sheng","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bmcl.2013.11.037","article-title":"Synthesis and evaluation of novel azoles as potent antifungal agents","volume":"24","author":"Li","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib80","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1747-0285.2012.01398.x","article-title":"Synthesis and biological evaluation of triazole derivatives as potential antifungal agent","volume":"80","author":"Chai","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.03.020_bib81","first-page":"1066","article-title":"Discovery of highly potent antifungal triazoles by structure-based lead fusion","volume":"2","author":"Wang","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib82","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1016\/j.bmcl.2010.03.014","article-title":"Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives","volume":"20","author":"Xu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib83","first-page":"653","article-title":"Discovery of highly potent triazole antifungal agents with piperidine-oxadiazole side chains","volume":"6","author":"He","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib84","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.ejmech.2010.09.070","article-title":"Novel conformationally restricted triazole derivatives with potent antifungal activity","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib85","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/molecules22071150","article-title":"Design, synthesis, and biological activity of new triazole and nitro-triazole derivatives as antifungal agents","volume":"22","author":"Sadeghpour","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.03.020_bib86","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/fmc-2017-0295","article-title":"Discovery of benzylthio analogs of fluconazole as potent antifungal agents","volume":"10","author":"Motahari","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib87","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib88","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.bmcl.2012.02.042","article-title":"New triazole derivatives as antifungal agents: synthesis via click reaction, in\u00a0vitro evaluation and molecular docking studies","volume":"22","author":"Zou","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ardp.201500313","article-title":"Synthesis, in\u00a0vitro biological evaluation, and molecular docking of new triazoles as potent antifungal agents","volume":"349","author":"Li","year":"2016","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2019.03.020_bib90","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bmcl.2008.12.026","article-title":"Synthesis and antifungal activity of 1, 2, 3-triazole containing fluconazole analogues","volume":"19","author":"Aher","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib91","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1016\/j.tet.2006.09.021","article-title":"Design and synthesis of fluconazole\/bile acid conjugate using click reaction","volume":"62","author":"Pore","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.03.020_bib92","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cclet.2016.11.027","article-title":"New triazole derivatives containing substituted 1,2,3-triazole side chains: design, synthesis and antifungal activity","volume":"28","author":"Chen","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.03.020_bib93","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.14233\/ajchem.2014.15956","article-title":"Synthesis and evaluation of some substituted heterocyclic fluconazole analogues as antifungal agents","volume":"26","author":"Wang","year":"2014","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib94","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1039\/C5OB00590F","article-title":"Design and synthesis of new fluconazole analogues","volume":"13","author":"Pore","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib95","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/j.ejmech.2011.02.001","article-title":"Design, synthesis and antifungal evaluation of 1-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-1H-1,2,4-triazol-5(4H)-one","volume":"46","author":"Jiang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib96","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1016\/j.bmcl.2011.06.008","article-title":"Synthesis, in\u00a0vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents","volume":"21","author":"Jiang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib97","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2004.03.004","article-title":"Synthesis of novel substituted tetrazoles having antifungal activity","volume":"39","author":"Upadhayaya","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib98","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/cmdc.201402320","article-title":"From antidiabetic to antifungal: discovery of highly potent triazole\u2013thiazolidinedione hybrids as novel antifungal agents","volume":"9","author":"Wu","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.03.020_bib99","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.bmcl.2007.04.038","article-title":"Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety","volume":"17","author":"Lebouvier","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib100","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ejmech.2010.01.062","article-title":"Design, synthesis and determination of antifungal activity of 5(6)-substituted benzotriazoles","volume":"45","author":"Patel","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib101","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bmcl.2009.11.071","article-title":"Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents","volume":"20","author":"Borate","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib102","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.bmcl.2008.04.056","article-title":"Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents","volume":"18","author":"Liu","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib103","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.bmcl.2011.06.022","article-title":"Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity","volume":"21","author":"Borate","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib104","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2174\/1389557514666141106130146","article-title":"Chemical and medicinal versatility of dithiocarbamates: an overview","volume":"14","author":"Bala","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib105","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bmcl.2011.12.033","article-title":"Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata","volume":"22","author":"Monti","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib106","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejmech.2014.01.009","article-title":"Synthesis, antifungal activities and molecular docking studies of novel 2-(2, 4-difluorophenyl)-2-hydroxy-3-(1H-1, 2, 4-triazol-1-yl) propyl dithiocarbamates","volume":"74","author":"Zou","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11030-014-9548-0","article-title":"Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity","volume":"19","author":"Hashemi","year":"2015","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2019.03.020_bib108","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/S0960-894X(03)00378-0","article-title":"1,2,4-Triazolo mercapto and aminonitriles as potent antifungal agents","volume":"13","author":"Collin","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib109","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bmc.2015.02.011","article-title":"Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents","volume":"23","author":"Hashemi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01106-16","article-title":"In\u00a0vitro activities of novel azole compounds ATTAF-1 and ATTAF-2 against fluconazole-susceptible and-resistant isolates of Candida species","volume":"61","author":"Fakhim","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.03.020_bib111","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.bmcl.2017.10.020","article-title":"Novel potentially antifungal hybrids of 5-flucytosine and fluconazole: design, synthesis and bioactive evaluation","volume":"27","author":"Fang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib112","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.03.020_bib113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0149-2918(02)85005-6","article-title":"Clinafloxacin versus piperacillin\/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center","volume":"24","author":"Siami","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejmech.2019.03.020_bib114","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/138955706776361493","article-title":"Structural features of new quinolones and relationship to antibacterial activity against Gram-positive bacteria","volume":"6","author":"Emami","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.020_bib115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.ejmech.2019.03.020_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2019.03.020_bib117","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.42.2.241","article-title":"Amino acid substitutions in the cytochrome P-450 lanosterol 14\u03b1-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents","volume":"42","author":"Sanglard","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.03.020_bib118","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib119","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijantimicag.2005.12.005","article-title":"Resistance mechanisms in fluconazole resistant Candida albicans isolates from vaginal candidiasis","volume":"27","author":"Cernicka","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.03.020_bib120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1574-6968.1995.tb07797.x","article-title":"Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug","volume":"131","author":"Venkateswarlu","year":"1995","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2019.03.020_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12154-014-0121-1","article-title":"Resistance to antifungals that target CYP51","volume":"7","author":"Parker","year":"2014","journal-title":"J.\u00a0Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib122","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2019.03.020_bib123","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s10096-012-1634-6","article-title":"The effect of biomaterials and antifungals on biofilm formation by Candida species: a review","volume":"31","author":"Cu\u00e9llar-Cruz","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.03.020_bib124","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","article-title":"Candida biofilms and their role in infection","volume":"11","author":"Douglas","year":"2003","journal-title":"Trends Microbiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419302314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T11:08:40Z","timestamp":1694689720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419302314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":124,"alternative-id":["S0223523419302314"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.020","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current advances of triazole alcohols derived from fluconazole: Design, in\u00a0vitro and in silico studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}